Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG, total Ab
Testing Method Category
Mixed
Testing Method
kits (ELISA; CLIA; LFIA)
Testing Method - Additional Info
3 different IgG-ELISAs (EUROIMMUN IgG and NCP-IgG ELISA, Wantai ELISA), 2 CLIA (Elecsys, LIAISON) and 2 lateral flow tests (MEDsan IgM/IgG-Rapid-Test, Wantai Rapid Test) and subsequently correlated to neutralization titers.
Reported Performance
Sensitivity: 99% (NT), 98% (Wanati ELISA), 92.86% (EI IgG ELISA), 88.89% (EI NCP ELISA), 94.95% (Elicsys), 84% (LIAISON), 88.78% (Wantai rapid T), 92.93% (MedSan rapid T)
Sample Size
100 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements